What is the diffuse large lymphoma B-cell?

diffuse large lymphoma B-cell (DLBCL) is a type of cancer that affects white blood cells, lymph nodes and other parts of the lymphatic system. DLBCL primarily affects white blood cells that are produced in bones. These cells, called lymphocytes of type B, grow larger than usual and reproduce faster. These cells, unlike most other cancer cells, cannot be observed. As a result, they are dispersed or dispersed in the affected areas of the patient's lymphatic system.

There is no known individual cause of diffuse large B-cell lymphoma, but it has been shown that several factors increase the likelihood of disease development. It seems that individuals with repeated exposure to certain herbicides or those who have a history of immunosuppressive use are at higher risk. Patients who have health conditions that affect immune systems are also more likely to develop DLBCL.

often distract a large B-cell lymphoma from cancer to other paRTS body. If it exists independently, the most common symptoms of the disease are weight loss, fever and night sweating. Occasionally lymph nodes in the throat, armpits and weakness can increase or develop growth. These growth are generally painless.

Preliminary diagnosis of diffusion large B-cell lymphoma is often performed by blood testing. The presence of dehydrogenase lactose (LDH), a chemical, which is produced by damaged tissues, in addition to abnormal blood cell numbers usually implies further testing. Biopsy of suspicious lymph glands or, rarely bone marrow biopsy are generally used to confirm diagnosis.

The primary treatment of diffuse large B-cell lymphoma is chemotherapy. During each session, a combination of doxorubicin, rituximab, cyclophosphamide and vincristin is given. The patient often completed the course. This process is usually repeated several times. To the patientIt is restored between these treatments.

Cancer lymphocytes that are damaged by radiation are not able to repair or multiply, so radiation therapy can also be useful in patients with DLBCL. The diffuse nature of DLBCL makes surgery to a large extent ineffective. However, the surgery may rarely be necessary to remove or repair the areas that have been damaged by this disease.

The chances of recovering from the diffuse large B-cell lymphoma are generally fair when cancer is discovered in the first or two phase. However, the aggressive nature of the disease is less likely to survive from its later stages. Elderly patients and those who generally have poor health will also be less likely to recover. In cases where cancer has spread to other parts of the body or when there is a large tissue damage, the prognosis is also poor.